These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31000859)

  • 1. Gastrointestinal and pancreatic neuroendocrine tumours and carcinomas; a review of rare tumour type.
    Siddiqa A; Adel H; Khan SA; Huda F; Sattar A
    J Pak Med Assoc; 2019 Apr; 69(4):533-540. PubMed ID: 31000859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CT and MRI findings of primary hepatic neuroendocrine neoplasm].
    Li JK; Wang M; Yuan J; Song ZG
    Zhonghua Zhong Liu Za Zhi; 2017 Aug; 39(8):600-606. PubMed ID: 28835083
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphological imaging of gastroenteropancreatic neuroendocrine tumours].
    Camera L; Bresciani M; Soscia E; Percopo V; Mainenti PP; Salvatore M
    Minerva Endocrinol; 2001 Sep; 26(3):123-8. PubMed ID: 11753234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron-emission tomography as a radiological technique in neuroendocrine gastrointestinal tumors.
    Eriksson B; Lilja A; Ahlström H; Bjurling P; Bergström M; Lindner KJ; Långström B; Oberg K
    Ann N Y Acad Sci; 1994 Sep; 733():446-52. PubMed ID: 7978893
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroendocrine tumours: clinical presentation and management of localized disease.
    Kulke MH
    Cancer Treat Rev; 2003 Oct; 29(5):363-70. PubMed ID: 12972355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced ultrasonography in evaluating hepatic metastases from neuroendocrine tumours.
    Massironi S; Conte D; Sciola V; Pirola L; Paggi S; Fraquelli M; Ciafardini C; Spampatti MP; Peracchi M
    Dig Liver Dis; 2010 Sep; 42(9):635-41. PubMed ID: 20172770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT/MRI of neuroendocrine tumours.
    Reznek RH
    Cancer Imaging; 2006 Oct; 6(Spec No A):S163-77. PubMed ID: 17114072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
    Sigel CS
    Cancer Cytopathol; 2018 Dec; 126(12):980-991. PubMed ID: 30485690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gastroenteropancreatic neuroendocrine tumours (carcinoid tumours): definition, clinical aspects, diagnosis and therapy].
    Bodelier AG; Haak HR
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1868-72. PubMed ID: 16970007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of vesicle proteins in the diagnosis and treatment of neuroendocrine tumors.
    Nilsson O; Jakobsen AM; Kölby L; Bernhardt P; Forssell-Aronsson E; Ahlman H
    Ann N Y Acad Sci; 2004 Apr; 1014():280-3. PubMed ID: 15153446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours.
    Gibril F; Jensen RT
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S106-20. PubMed ID: 15077919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural course of small, asymptomatic neuroendocrine pancreatic tumours in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.
    Kann PH; Balakina E; Ivan D; Bartsch DK; Meyer S; Klose KJ; Behr T; Langer P
    Endocr Relat Cancer; 2006 Dec; 13(4):1195-202. PubMed ID: 17158764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond.
    Sorbye H; Baudin E; Perren A
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):683-698. PubMed ID: 30098724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
    Oberg K; Eriksson B
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):265-76. PubMed ID: 15763700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
    Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options.
    Arnold R
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):491-505. PubMed ID: 16183523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of clinical outcome in treated neuroendocrine tumours of carcinoid type using functional volumes on 111In-pentetreotide SPECT imaging.
    Gopinath G; Ahmed A; Buscombe JR; Dickson JC; Caplin ME; Hilson AJ
    Nucl Med Commun; 2004 Mar; 25(3):253-7. PubMed ID: 15094443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard imaging techniques for neuroendocrine tumors.
    Bushnell DL; Baum RP
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):153-62, ix. PubMed ID: 21349416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates.
    Chai SM; Brown IS; Kumarasinghe MP
    Histopathology; 2018 Jan; 72(1):153-167. PubMed ID: 29239038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging of gastroenteropancreatic neuroendocrine tumors.
    Miederer M; Weber MM; Fottner C
    Gastroenterol Clin North Am; 2010 Dec; 39(4):923-35. PubMed ID: 21093764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.